在心脏性休克患者中延长的Impella5. 5支持:单中心回顾性分析
Ioana Dumitru1, Jonathan DeWolf2, Maria Sevillano1
1Division of Advanced Heart Failure and Cardiac Transplant, Tampa General Hospital, University of South Florida, Tampa, FL 33606, USA.
Journal of clinical medicine
|August 28, 2025
概括
长期使用Impella5. 5进行机械循环支持超过14天,对心脏性休克患者显示出有前途的结果. 这种延长的支持有助于心脏恢复,
科学领域:
- 心脏病学
- 机械循环支持
- 心脏衰竭的治疗方法
背景情况:
- 心脏性休克 (CS) 患者通常需要超过14天的机械循环支持.
- 长期使用Impella 5. 5可能会改善这些重症患者的治疗结果.
研究的目的:
- 评估心脏病性休克患者长期使用Impella 5. 5的经验和结果.
- 评估Impela 5. 5在经过FDA批准的14天后的安全性和有效性.
主要方法:
- 在14天内接受Impella 5.5支持的64名患者的回顾性评估 (2023年1月至2024年6月).
- 收集的数据包括人口统计,心力衰竭病因和临床过程.
- 结果分析包括存活,心脏恢复,心脏移植 (OHT) 和左心室辅助装置 (LVAD) 植入.
主要成果:
- 支持Impela 5. 5的平均持续时间为27. 1天.
- 释放或高级治疗后的整体存活率为81. 3% (52/ 64).
- 通过OHT (27),心脏恢复 (13),或LVAD (12),患者获得了结果.
结论:
- 在心脏性休克患者中,Impella 5. 5 显示能持续超过 14 天.
- 扩大Impella5. 5的使用需要进一步研究心脏恢复和作为通往先进疗法的桥梁.
相关概念视频
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21


